19 results
S-3ASR
DAWN
Day One Biopharmaceuticals, Inc.
14 Sep 23
Automatic shelf registration
5:28pm
provisions, rights in the event of our liquidation, dissolution or the winding up, voting rights and rights to convert into common stock.
Debt … ” in our Annual Report on Form 10-K for the year ended December 31, 2022, which is incorporated by reference in this prospectus.
Voting rights
Except
424B5
DAWN
Day One Biopharmaceuticals, Inc.
7 Jun 23
Prospectus supplement for primary offering
4:57pm
in the event of our liquidation, dissolution or the winding up, voting rights and rights to convert into common stock.
Debt Securities
We may offer … ended December 31, 2021, which is incorporated by reference in this prospectus.
Voting rights
Except as otherwise expressly provided in our restated
424B5
DAWN
Day One Biopharmaceuticals, Inc.
6 Jun 23
Prospectus supplement for primary offering
4:21pm
this prospectus, including redemption provisions, rights in the event of our liquidation, dissolution or the winding up, voting rights and rights … of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence
PRE 14A
58osu8fgp cm
18 Apr 23
Preliminary proxy
4:05pm
424B5
ypzeyw
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
zbedcthmf1tie
14 Jun 22
Prospectus supplement for primary offering
7:39am
S-3
3z3n15ob9vqb6 x3ouvv
1 Jun 22
Shelf registration
4:06pm
DEF 14A
wd6smfguxujstz e77w
28 Apr 22
Definitive proxy
4:44pm
10-K
EX-4.3
s2740y500hdke0j
7 Mar 22
Annual report
7:36am
424B4
nm3otit 8hslh6
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
EX-3.1
dejam vny9s7i6jlv
24 May 21
IPO registration (amended)
6:16am
S-1/A
i8yh5tbjthbls3
24 May 21
IPO registration (amended)
6:16am
S-1
cusf3mq
4 May 21
IPO registration
4:12pm
S-1
EX-3.1
scgio ebx2oh
4 May 21
IPO registration
4:12pm
DRS
dbwf0w
19 Mar 21
Draft registration statement
12:00am
DRS
EX-3.1
m7noumr4 0w
19 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next